CompletedPHASE2, PHASE3NCT01385826

Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis

Studying Juvenile idiopathic arthritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Pierre Quartier dit Maire, MD, PhD
hospital Necker Enfants Malades
Intervention
Anti-tumor necrosis factor alpha monoclonal antibody(drug)
Enrollment
34 enrolled
Eligibility
4 years · All sexes
Timeline
20112015

Study locations (1)

Collaborators

Abbott · URC-CIC Paris Descartes Necker Cochin

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01385826 on ClinicalTrials.gov

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile idiopathic arthritis

← Back to all trials